The FDA has released draft guidance outlining an approval pathway for individualized therapies aimed at ultra-rare diseases, building on a framework first outlined by agency leaders in November. The ...
Multi-omics profiling of residual cancer burden after neoadjuvant hormonal therapy guides subtype-directed treatment in high-risk and locally advanced prostate cancer. Predictive associations between ...
French President Emmanuel Macron has unveiled updates to France's doctrine on the potential use of nuclear weapons, marking what he described as a new phase in the country's deterrence strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results